Reuters logo
BRIEF-Oncosec to present new clinical data from phase 2 combination study
February 8, 2017 / 11:13 AM / 9 months ago

BRIEF-Oncosec to present new clinical data from phase 2 combination study

Feb 8 (Reuters) - Oncosec Medical Inc

* Oncosec to present new clinical data from phase 2 combination study at ASCO-SITC clinical immuno-oncology symposium and corporate updates at two investment conferences in February Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below